Society of Hematologic Oncology (SOHO) 2019
September 11, 2019
At the Society of Hematologic Oncology (SOHO) 2019 Annual Meeting in Houston, TX, USA, clinical trial data from two of our trials HORIZON and ANCHOR were presented. In an oral presentation, data from the pivotal Phase 2 HORIZON clinical trial were presented as part of the meeting’s multiple myeloma session. Additionally, two posters focused on the ANCHOR and HORIZON clinical trials evaluating melflufen in RRMM were displayed at the meeting.
See the presentation and the posters below.